Always cite the published version, so the author(s) will receive recognition through services that track citation counts, e.g. Scopus. If you need to cite the page number of the author manuscript from TSpace because you cannot access the published version, then cite the TSpace version in addition to the published version using the permanent URI (handle) found on the record page.
3

Abstract
Context
The experience of death anxiety in patients with advanced cancer has been understudied partly due to the lack of a tailored measure for this population. The Death and Dying Distress Scale (DADDS) was constructed to address this gap. Although an initial version of this instrument has shown promising psychometric properties, validation of the finalized version is needed.
Objectives
This study aims to validate the recent 15-item DADDS by examining its factor structure and construct validity.
Methods
Sixty participants with advanced or metastatic cancer were recruited from the Princess Margaret Cancer Centre, Toronto, Canada, into a pilot trial of a psychological intervention. This paper analyzes the baseline measures on death anxiety, depressive symptoms (PHQ-9, SCID), generalized anxiety (GAD-7), and preparation for end of life (QUAL-EC). Exploratory factor analysis was conducted. Construct validity was assessed by correlations between measures.
Results
Factor analysis revealed a dominant single factor explaining over 75% of the shared variation between items. Factor loadings were high, ranging from 0.57 to 0.86. Item communalities were evenly ranged from 0.33 to 0.75 and with the 15:1 variable to factor ratio, suggest the viability of parameter estimates despite the small sample size. Cronbach's alpha was 0.95. Death anxiety was associated with less preparation for end of life, r = -0.68, p < 0.0001, and more generalized anxiety, r = 0.63, p < 0.0001, and depressive symptom severity, r = 0.50, p < 0.0001. Individuals with major depression had greater death anxiety than the non-depressed, mean difference = 17, CI .95 = (1.5, 33), as did individuals with minor depression, mean difference = 25, CI .95 = (10, 41) .
Conclusion
The DADDS is a valid measure of death anxiety in patients with advanced cancer. It may provide useful information in the assessment and treatment of distress in patients near the end of life.
INTRODUCTION
Relief of death anxiety may be considered a central outcome in palliative care (1) . In cancer populations, death anxiety has been associated with pain and physical distress (1, 2, 3), psychiatric comorbidity, including generalized anxiety and depression (1, 2, 3, 4) , impaired spiritual wellbeing and quality of life (4, 5, 6) , and psychological burden in family caregivers (6) .
Nonetheless, research on death anxiety and its treatment in advanced cancer has been rare, for example, in comparison to depression (7, 8) , despite the potential for death anxiety to be more common (4) . This omission may be due to multiple factors, which include problems of access to patients with terminal illness (9), a theoretical tradition among death anxiety researchers that has emphasized the unconscious effects of mortality salience on human behavior (10, 11, 12, 13) , and the lack of a tailored measurement tool for use with patients with advanced cancer (14) . To promote the study of death anxiety in this clinical population, we have designed a 15-item self-report measure, the Death and Dying Distress Scale (DADDS) (4), tailored to this context. The purpose of the present study was to examine the reliability and validity of this measure in patients with advanced or metastatic cancer.
Early assessments of death anxiety employed projective methods to avoid defensive biases elicited by direct methods (15) . Over time, projective tests have been largely replaced by selfreport measures due to their greater reliability, validity and ease of administration and as part of a general shift away from psychodynamics (16) . Although several self-report scales have been developed to assess death anxiety, these were not specifically designed for use in the context of imminent dying and death from illness (17, 18, 19, 20, 21, 22 The DADDS was designed as an empirical outcome to assess the effectiveness of psychosocial and early palliative care interventions to alleviate death anxiety in advanced cancer. It was intended for use in patients with a prognosis greater than 6 months to allow sufficient time to intervene. Individuals in this circumstance are as or more engaged in the tasks of living than they are with dying (24) . Their struggle is one of "double awareness," which refers to balancing the possibilities that remain in life against the despair evoked by the finality of death (25) . The DADDS focuses on concerns raised by impending mortality that affect the ability to live meaningfully in the time until death, including psychosocial concerns about lost opportunities and time and impact on others, and anticipatory fears about the process of dying.
It avoids assessing sensitivity to death-related cues, such as exposure to the death of others (21), death-related environments (22) , and life-threatening events unrelated to disease (20).
The measure focuses on assessment of clinically significant distress such that high scores indicate the need for treatment. It does not assess death attitudes for which the intended effect of clinical intervention is ambiguous (26) . An initial version of the DADDS was found to have good reliability and validity, and the scale was modified into its final form with 15 items (4). The present study examines its factor structure in a sample of 60 participants with advanced cancer. As evidence of construct validity, we hypothesized that the DADDS would be negatively associated with preparation for the end of life, which serves as a second measure of death anxiety, and positively associated with generalized anxiety and depression, which are also distress-related constructs.
METHODS
Participants and Procedure
This study was approved by the University Health Network Research Ethics Board.
Participants were outpatients with advanced cancer from the Princess Margaret Cancer Centre, part of the University Health Network, in Toronto, Canada. They were recruited from June, 2011 to February, 2012 into a phase 2b pilot study of a psychological intervention to 6 alleviate distress (27, 28) . After providing written informed consent, participants were assessed on the Short Orientation-Memory-Concentration Test (SOMC) (29), a measure of cognitive impairment, and Karnofsky Performance Status (30) , and gave other basic medical and demographic information. The present paper is an analysis of the baseline data. Evaluation of Mental Disorders (PRIME-MD), a widely used tool to screen for mental health disorders in primary care (33) and which has been used with advanced cancer patients (34) .
Scores on the measure range from 0-27, with higher scores indicating greater depressive symptom severity. The SCID is a semi-structured interview that allows interviewers to make diagnoses based on DSM-IV-TR diagnostic criteria (35) . It is considered a standard for research diagnoses of depression and has been used in advanced cancer (36) . SCID scores categorize individuals into those with no depression, minor depression, and major depression.
Anxiety was assessed with the Generalized Anxiety Disorder-7 (GAD-7) (37), a widely used and validated 7-item self-report measure from the PRIME-MD (33) that has been administered in cancer populations (38) . Scores may range from 0 to 21, with higher scores indicating greater generalized anxiety.
Preparation for the end of life was assessed using a 4-item subscale from the Quality of Life at the End of Life -Cancer Scale (QUAL-EC) (39, 40) . The scale was specifically developed to assess quality of life in palliative populations and has been validated in advanced cancer (39, 40) . The preparation subscale assesses financial and emotional concerns that indicate a lack of preparedness for death (e.g. Thoughts of dying frighten me; I worry that my family is not 8 prepared to cope with the future). Scores may range from 4-20, with higher scores indicating greater preparedness.
Statistical Analysis
Descriptive statistics were calculated on the sample. The primary analysis was an exploratory factor analysis with principal axis factoring. The scree plot was examined to determine the number of factors to extract and factor loadings were reviewed to interpret dimensions. The Kaiser-Meyer-Olkin Measure of Sampling Adequacy and Bartlett's test of sphericity assessed the appropriateness of factor analysis. The sample size required for recovery of the population factor structure depends on the magnitude of the communalities and the variable to factor ratio (41) . Simulations indicate that a sample size of 60 is sufficient for good recovery when the variable to factor ratio is at least 20:3 and the range of communalities is wide (e.g. ranging from 0.2 to 0.8 in even increments) (41) . These conditions were examined to also determine the appropriateness of factor analysis. Internal reliability was assessed by Cronbach's alpha and the mean inter-item correlation. Correlations were calculated between the DADDS and other continuous study variables to assess construct validity. The association between the DADDS and SCID categories was assessed by ANOVA. Post-hoc comparisons were conducted using Tukey's test. Table 1 provides descriptive statistics on the sample, which was mostly female, Caucasian, married and educated above the high school level. The most common cancer site was gastrointestinal and the mean time since cancer diagnosis was 2.5 years. Based on the SCID, one third of participants were diagnosed with some form of depression, with 16% of participants meeting criteria for major depression. The majority of participants were relatively high functioning in terms of physical capability, with 70% of participants scoring 80 ("normal activity with effort, some signs or symptoms of disease") and above on performance status.
RESULTS
The DADDS took approximately 5-10 minutes for patients to complete. In total, 59 participants provided complete DADDS data and were included in the factor analysis. The scree plot indicated the presence of a dominant single factor (see Figure 1 ). This factor accounted for just over 75% of the common variance among items. The Kaiser-Meyer-Olkin Measure of 9 Sampling Adequacy was 0.90 and Bartlett's test was significant, Chi-square (df) = 719 (105), p < 0.0001, both indicating that factor analysis was appropriate. Table 2 
DISCUSSION
This study was a preliminary examination of the validity of the Death and Dying Distress Scale in a sample of patients with advanced cancer. Consistent with the psychometrics of an earlier version of the scale (4), the 15-item DADDS demonstrated a single factor structure, was internally reliable and showed good construct validity.
As hypothesized, death anxiety was associated with less preparation for end of life.
Preparedness may depend upon adequate financial planning, discussion of how dependency needs are to be met, and sufficient time to complete one's unfinished business. Research has shown that advance care planning for end of life decisions can have a marked effect on lowering distress in palliative populations (42) . Professional psychosocial support may facilitate family communication with healthcare teams and promote psychological adaptation (43) .
Death anxiety was associated with symptoms of depression and anxiety. Insofar as mortalityrelated concerns underlie these more general presentations of distress, the DADDS may provide a useful focus for clinicians seeking to address antecedent factors. Individuals with minor depression were found to have similar levels of death anxiety as those with major depression, suggesting that even sub-threshold depression in advanced disease may be associated with clinically significant levels of distress that may benefit from intervention.
Study limitations include self-reported data which may affect the reliability of results. The low recruitment rate, small sample size and the conduct of the study as part of a psychotherapeutic trial may have affected the representativeness of the sample, which in turn affect the replicability and generalizability of the findings. Most participants were ambulatory, female, Caucasian, married, educated above the high school level, and attending a large urban cancer center. Individuals were excluded if they did not speak English sufficiently well to provide informed consent. The low recruitment rate is typical of psychological studies in this setting (44) and favored selection of individuals who were physically healthy enough to participate in the study. The sample may under-represent individuals struggling with death anxiety and other distress who were unable or unwilling to discuss their concerns with a therapist as part of a trial. Lastly, this study was a secondary analysis of pilot trial data, which limited our ability to compare the DADDS to additional measures of death anxiety beyond the QUAL-EC Preparation for End of Life subscale.
Future research may seek to better test the DADDS in a larger and more representative sample of patients with advanced cancer, with special attention to issues of discriminant validity, stability of assessment over time, and patient acceptance of the instrument. In conclusion, the 15-item DADDS is a promising measure of death anxiety in advanced disease that may provide useful information to clinicians and researchers seeking to intervene with distressed individuals near the end of life. Great to extreme (60-75) 10% ( 
